MARA Holdings
MARA
Tesla
TSLA
Strategy
MSTR
Coinbase
COIN
Meritage Homes
MTH
US Stock MarketDetailed Quotes
MNKD MannKind
- 5.230
- +0.010+0.19%
Close Mar 24 16:00 ET
1.59BMarket Cap52.30P/E (TTM)
5.280High5.200Low1.32MVolume5.230Open5.220Pre Close6.93MTurnover0.44%Turnover Ratio52.30P/E (Static)303.59MShares7.63052wk High-20.12P/B1.56BFloat Cap3.97052wk Low--Dividend TTM298.49MShs Float121.550Historical High--Div YieldTTM1.53%Amplitude0.666Historical Low5.229Avg Price1Lot Size
About MannKind Company
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Company Profile
SymbolMNKD
Company NameMannKind
Listing DateJul 28, 2004
Issue Price14.00
Founded1991
CEOMr. Michael E. Castagna, Pharm.D.
MarketNASDAQ
Employees407
Fiscal Year Ends12-31
Address1 Casper Street
CityDanbury
ProvinceConnecticut
CountryUnited States of America
Zip Code06810
Phone1-818-661-5000
Websitehttp://www.mannkindcorp.com
Company Executives
- Name
- Position
- Salary
- Michael E. Castagna, Pharm.D.
- Director and Chief Executive Officer
- 7.07M
- Dr. Burkhard Blank,M.D.
- Executive Vice President, Research and Development and Chief Medical Officer
- --
- Christopher B. Prentiss
- Chief Financial Officer and Principal Accounting Officer
- --
- Lauren M. Sabella
- Executive Vice President, Operations
- 1.91M
- Dr. Stuart A. Tross, PhD
- Executive Vice President, Human Resources
- 2.22M
- Sanjay R. Singh
- Executive Vice President, Technical Operations
- --
- Dr. James S. Shannon, M.D.,M.R.C.P.
- Chairman of the Board
- 255.64K
- Dominic Marasco
- President, Endocrine Business Unit
- --
- Steven B. Binder
- Director
- 2.34M
- Ronald J. Consiglio
- Independent Director
- 241.73K
- Christine A. Mundkur
- Independent Director
- 226.73K
- Anthony C. Hooper
- Independent Director
- 233.14K
- Dr. Sabrina Kay, PhD
- Independent Director
- 221.73K
- Dr. Michael A. Friedman M.D.
- Independent Director
- 229.23K
- Jennifer Grancio
- Independent Director
- 221.73K
- Dr. David B. Thon, J.D.,PhD
- General Counsel and Secretary
- 2.34M
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.